Sigrid Carlsson
51 – 60 of 70
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age : Data from the malmö preventive project
- Contribution to journal › Article
-
Mark
Functional and Oncologic Outcomes Between Open and Robotic Radical Prostatectomy at 24-month Follow-up in the Swedish LAPPRO Trial
- Contribution to journal › Article
-
Mark
Prostate cancer risk assessment in men with an initial P.S.A. below 3 ng/mL : results from the Göteborg randomized population-based prostate cancer screening trial
- Contribution to journal › Article
- 2017
-
Mark
Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study
- Contribution to journal › Article
- 2016
-
Mark
Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice : A microsimulation screening analysis
- Contribution to journal › Article
-
Mark
Oncologic and functional outcomes 1 year after radical prostatectomy for very low risk prostate cancer. Results from the prospective LAPPRO trial.
- Contribution to journal › Article
- 2015
-
Mark
Clinical Consultation Guide : How to Optimize the Use of Prostate-specific Antigen in the Current Era
- Contribution to journal › Article
- 2014
-
Mark
Prostate cancer mortality in areas with high and low prostate cancer incidence.
- Contribution to journal › Article
-
Mark
Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening : Population based cohort study
- Contribution to journal › Article
-
Mark
It Ain't what you do, it's the way you do it : Five golden rules for transforming prostate-specific antigen screening
- Contribution to journal › Article
